Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 9, 2014, Pages 1341-1348

  El Jawahri, Areej ^a,b   Pidala, Joseph ^c   Inamoto, Yoshi ^d   Chai, Xiaoyu ^d   Khera, Nandita ^e   Wood, William A ^f   Cutler, Corey ^g   Arora, Mukta ^h   Carpenter, Paul A ^d   Palmer, Jeanne ⁱ   Flowers, Mary ^d   Weisdorf, Daniel ^h   Pavletic, Steven ^j   Jaglowski, Samantha ^k   Jagasia, Madan ^l   Lee, Stephanie J ^d   Chen, Yi Bin ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

^k THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Age; Chronic graft versus host disease; Functional status; Quality of life

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FITNESS; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; QUALITY OF LIFE; ADOLESCENT; CHRONIC DISEASE; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84905585991     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.05.001     Document Type: Article

References (37)

1. Wong F.L., Francisco L., Togawa K., et al. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood 2010, 115:2508-2519.
2. Watson M., Buck G., Wheatley K., et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004, 40:971-978.
3. Bieri S., Roosnek E., Helg C., et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008, 42:819-827.
4. Chiodi S., Spinelli S., Ravera G., et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000, 110:614-619.
5. Deschler B., Binek K., Ihorst G., et al. Prognostic factor and quality of life analysis in 160 patients aged > or=60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 16:967-975.
6. Frohling S., Schlenk R.F., Kayser S., et al. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B. Blood 2006, 108:3280-3288.
7. Cancer and Leukemia Group B, Farag S.S., Archer K.J., et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood 2006, 108:63-73.
8. Kiss T.L., Sabry W., Lazarus H.M., Lipton J.H. Blood and marrow transplantation in elderly acute myeloid leukaemia patients - older certainly is not better. Bone Marrow Transplant 2007, 40:405-416.
9. Sorror M.L., Appelbaum F.R. Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia. Expert Rev Hematol 2013, 6:547-562.
10. Appelbaum F.R. Preparative regimens and ageism. Biol Blood Marrow Transplant 2011, 17:1419-1420.
11. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
12. Walter R.B., Othus M., Borthakur G., et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. JClin Oncol 2011, 29:4417-4423.
13. Duell T., van Lint M.T., Ljungman P., et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997, 126:184-192.
14. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. New Engl J Med 1999, 341:14-21.
15. Sullivan K.M., Witherspoon R.P., Storb R., et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988, 72:546-554.
16. Wingard J.R., Piantadosi S., Vogelsang G.B., et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989, 74:1428-1435.
17. Loughran T.P., Sullivan K., Morton T., et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990, 76:228-234.
18. Lee S.J., Flowers M.E. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2008, 134-141.
19. Sutherland H.J., Fyles G.M., Adams G., et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997, 19:1129-1136.
20. Syrjala K.L., Chapko M.K., Vitaliano P.P., et al. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993, 11:319-327.
21. Pidala J., Kurland B., Chai X., et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
22. Chronic G.C. Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011, 17:1114-1120.
23. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
24. McQuellon R.P., Russell G.B., Cella D.F., et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997, 19:357-368.
25. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263.
26. McHorney C.A., Ware J.E., Lu J.F., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66.
27. Haley S.M., McHorney C.A., Ware J.E. Evaluation of the MOS SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale. JClin Epidemiol 1994, 47:671-684.
28. Lee S., Cook E.F., Soiffer R., Antin J.H. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002, 8:444-452.
29. Daughton D.M., Fix A.J., Kass I., et al. Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil 1982, 63:620-622.
30. Herzberg P.Y., Heussner P., Mumm F.H., et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:1707-1717.
31. Alyea E.P., Kim H.T., Ho V., et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005, 105:1810-1814.
32. Corradini P., Zallio F., Mariotti J., et al. Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. JClin Oncol 2005, 23:6690-6698.
33. McClune B.L., Weisdorf D.J. Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?. Curr Opin Hematol 2010, 17:133-138.
34. Brunner A.M., Kim H.T., Coughlin E., et al. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2013, 19:1374-1380.
35. Moser D.K., Heo S., Lee K.S., et al. 'It could be worse... lot's worse!' Why health-related quality of life is better in older compared with younger individuals with heart failure. Age Ageing 2013, 42:626-632.
36. Duke J., Leventhal H., Brownlee S., Leventhal E.A. Giving up and replacing activities in response to illness. JGerontol B Psychol Sci Soc Sci 2002, 57:P367-P376.
37. Piazza J.R., Charles S.T., Almeida D.M. Living with chronic health conditions: age differences in affective well-being. JGerontol B Psychol Sci Soc Sci 2007, 62:P313-P321.